Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Neutropenia 4Febrile Neutropenia 4Breast Neoplasms 2Thoracic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anemia, Refractory, with Excess of Blasts 1

Interventions

pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thoracic Neoplasms × pegylated granulocyte colony-stimulating factor × Classical hematology × Clear all
NCT07205536 2025-12-11

ANC-IIT-004

Affiliated Hospital of Nantong University

Phase 2 Recruiting
30 enrolled
Classical hematologyThoracic

Neutropenia, Thoracic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡